All news

CRPC: therapeutic options

Added: Friday 20 December 2013

Castration-resistant prostate cancer (CRPC) tends to have a poor prognosis. However, there has recently been an expansion in the number of different treatment options available. An article published in <cite>Touch Oncology</cite> reviews the therapies currently available. It was one of the website's most popular articles of 2013.


+  http://www.touchoncology.com/articles/castration-resistant-prostate-cancer-chemotherapies-and-molecular-targets


//